Prioritizing rs7294 as a mirSNP contributing to warfarin dosing variability

Area of Science:

• Pharmacogenomics
• Molecular Biology
• Genetics

Background:

• Warfarin dose variability is influenced by genetic factors.
• The role of microRNA SNPs (mirSNPs) in warfarin pharmacogenetics is not fully understood.
• VKORC1, CYP2C9, and CYP4F2 genes are critical in warfarin metabolism.

Purpose of the Study:

• To investigate the role of mirSNPs in the 3'UTR of VKORC1, CYP2C9, and CYP4F2 genes.
• To elucidate a potential miRNA-mediated mechanism for warfarin dose variability.
• To evaluate the functional impact of mirSNPs on gene regulation.

Main Methods:

• Analysis of genotypic data from the 1000 Genomes dataset.
• Assessment of pair-wise linkage disequilibrium and allelic enrichment.
• In silico analysis of miRNA binding site stability.

Main Results:

• MirSNP rs7294 in the VKORC1 3'UTR showed linkage disequilibrium with other SNPs.
• rs7294 was consistently associated with higher warfarin dose requirements.
• In silico analysis predicted altered binding stability for hsa-miR-133a-3p, indicating miRNA-mediated gene regulation.

Conclusions:

• The study supports rs7294 as a functional variable influencing warfarin dose.
• Inclusion of rs7294 in dosing algorithms can improve population-specific warfarin dose accuracy.
• This finding contributes to understanding miRNA-mediated mechanisms in pharmacogenetics.